ABOUT THE COMPANY

Founded in 2000, BFutur Suisse SA, www.befutur.com, is a privately held Swiss biotech company, specialized in the conception and development of active ingredients for cosmetic applications. The company headquarters are in Geneva, Switzerland and its North-American branch in Montréal, Canada.

The company has developed an anti-aging and antioxidant skincare range named LA PEAU, based on the usage of a new proprietary molecular complex - the BCell. Stabilized after 4 years of research by prominent scientists & biotech experts from Geneva and Stanford Universities, the BeCell complex, is the basis of the 3 product skincare range LA PEAU; it is a revolutionary complex, stemming from years of research on the skin, that helps reduce the appearance of fine lines and wrinkles. Easily absorbed, it stimulates cellular metabolism to nourish and regenerate the skin. BeCell is free of any animal protein.

It is composed of the finest antioxidants, amino acids, oligo elements & vitamins with proven anti-wrinkle properties; it regulates the skin's moisture level while providing long-lasting hydration. LA PEAU projects an authentic Swiss luxury product line based upon perception of treatment qualities vs. purely cosmetic benefits. It has been launched as the most exclusive Swiss antioxidant product on the market, derived from years of biotech research - more effective than any other product on the market.

The texture is different than the normal creams & the instant feeling is one of purity & efficacy. Non-oily, LA PEAU penetrates fast into the skin, hydrates it immediately without leaving the messy greasiness on your face; the skin becomes much firmer.

The 3 products of the skincare range - Night, Day and Eye Contour - are easily absorbed due to their non-greasy texture. All products are non animal and fragrance free.

• Night Cream-Gel: Age Defying Complex
• Day Cream-Gel: Hydrating Complex
• Eye Contour: Soothing & Replenishing

The Team

Carla-Maria Khanjian, M.Sc.
CEO & President
carla@befutur.com

Irma Kayser-Khanjian, B.A.
Vice President, Operations
irma@befutur.com

Marc Baly
Finance Director
baly@befutur.com

Scientific Advisory Board

Dr. Philippe Tacchini, Stanford University
President, Edel Therapeutics, Geneva

Dr. Alfred Balbul, McGill University
Professor of Dermatology, Montreal

Dr. Thomas Knittel, Professor of Medicine, MBA (Kellogg)
Director, Novo Nordisk, Germany

Dr. Hrayr Shahinian, Director of Skull Institute
Cedars Sinai Hospital, Beverly Hills

Business Advisory Board

Marc Baly
MB Fiduciare SA, Geneva

Laurent Delifer, CEO
Navlink, Geneva

Clement Graves, Lawyer
Geneva, Switzerland

Pierre Laurin, Ph.D.
Ex-Vice Chairman, Merrill Lynch Canada